Ifg Advisory, LLC Astrazeneca PLC Transaction History

Ifg Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$36.86 - $41.49 $274,348 - $308,810	-7,443 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$34.76 - $39.72 $30,067 - $34,357	-865 Reduced 10.41%	7,443 $294,000
Q2 2018 Aug 02, 2018	SELL	$34.55 - $37.05 $1,451 - $1,556	-42 Reduced 0.5%	8,308 $291,000
Q1 2018 Apr 26, 2018	SELL	$32.97 - $36.63 $65,478 - $72,747	-1,986 Reduced 19.21%	8,350 $0
Q4 2017 Feb 01, 2018	SELL	$32.09 - $34.78 $1.11 Million - $1.2 Million	-34,645 Reduced 77.02%	10,336 $358,000
Q4 2017 Jan 29, 2018	BUY	$32.09 - $34.78 $1.44 Million - $1.56 Million	44,981	44,981 $371,000

1,360

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Ifg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Ifg Advisory, LLC with notifications on news.